Yuanyuan Ding Selected Research

Asialoglycoproteins

4/2017	Galactose-Containing Polymer-DOX Conjugates for Targeting Drug Delivery.
12/2014	Hepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug delivery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuanyuan Ding Research Topics

Disease

22	Neoplasms (Cancer) 04/2024 - 08/2010
12	Anaphylaxis (Anaphylactic Shock) 01/2023 - 09/2018
11	Inflammation (Inflammations) 02/2024 - 05/2015
10	Hypersensitivity (Allergy) 01/2023 - 01/2011
9	type 2C Congenital disorder of glycosylation 01/2023 - 09/2018
7	Pain (Aches) 01/2022 - 01/2016
5	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 01/2023
4	Hyperalgesia 08/2023 - 01/2016
4	Hepatocellular Carcinoma (Hepatoma) 04/2017 - 12/2014
3	Trigeminal Neuralgia (Tic Douloureux) 12/2021 - 01/2018
3	Asthma (Bronchial Asthma) 01/2021 - 01/2018
3	Neuralgia (Stump Neuralgia) 01/2018 - 12/2017
2	Stroke (Strokes) 11/2024 - 01/2023
2	Atherosclerosis 11/2024 - 01/2021
2	Triple Negative Breast Neoplasms 03/2024 - 01/2019
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2024 - 05/2015
2	Acute Coronary Syndrome 09/2023 - 12/2019
2	Neoplasm Metastasis (Metastasis) 02/2023 - 01/2017
2	Neurocognitive Disorders (Clerambault Syndrome) 01/2023 - 09/2022
2	Neuroinflammatory Diseases 01/2023 - 09/2022
2	Urticaria (Hives) 01/2023 - 01/2021
2	Chronic Urticaria 01/2023 - 12/2022
2	Cognitive Dysfunction 01/2023 - 09/2022
2	Heart Failure 11/2022 - 01/2022
2	Necrosis 02/2022 - 09/2020
2	Wounds and Injuries (Trauma) 02/2022 - 03/2021
2	Shock 01/2021 - 12/2020
2	Hypothermia 12/2020 - 09/2020
2	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 10/2020 - 01/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2018 - 03/2017
2	Breast Neoplasms (Breast Cancer) 01/2017 - 03/2016
1	Chronic Renal Insufficiency 04/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2024
1	Vascular Calcification 04/2024
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2024
1	Ulcerative Colitis 02/2024
1	Emergence Delirium 11/2023

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2016
10	Immunoglobulin E (IgE)IBA 02/2022 - 01/2018
9	CytokinesIBA 01/2023 - 12/2012
8	Histamine (Histamine Dihydrochloride)FDA Link 01/2023 - 09/2018
7	CalciumIBA 01/2023 - 01/2019
5	ChemokinesIBA 01/2023 - 01/2019
5	Phosphotransferases (Kinase)IBA 02/2022 - 01/2020
4	Substance PIBA 01/2023 - 01/2019
4	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2021 - 10/2018
3	CateninsIBA 05/2024 - 01/2023
3	Interleukin-6 (Interleukin 6)IBA 08/2023 - 01/2016
3	alpha-Linolenic Acid (Linolenic Acid)IBA 07/2023 - 01/2021
3	Therapeutic UsesIBA 02/2023 - 11/2022
3	SecretagoguesIBA 12/2022 - 03/2020
3	LipidsIBA 06/2021 - 09/2018
3	p-Methoxy-N-methylphenethylamineIBA 01/2021 - 03/2020
3	Interleukin-8 (Interleukin 8)IBA 12/2020 - 01/2019
3	Anti-Allergic Agents (Antiallergic Agents)IBA 12/2020 - 01/2020
3	QuercetinIBA 10/2020 - 01/2019
3	SteroidsIBA 01/2020 - 01/2018
3	Galactose (Galactopyranose)FDA LinkGeneric 04/2017 - 12/2014
2	Biomarkers (Surrogate Marker)IBA 04/2024 - 05/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2024 - 03/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 02/2023
2	Caspase 3 (Caspase-3)IBA 01/2024 - 02/2019
2	Anesthetics (Anesthetic Agents)IBA 11/2023 - 01/2023
2	AllergensIBA 07/2023 - 02/2022
2	AcidsIBA 07/2023 - 12/2022
2	Indicators and Reagents (Reagents)IBA 02/2023 - 01/2021
2	AntioxidantsIBA 02/2023 - 08/2019
2	Sevoflurane (Ultane)FDA LinkGeneric 09/2022 - 01/2021
2	Polysaccharides (Glycans)IBA 02/2022 - 03/2021
2	IgE Receptors (Fc epsilon RI)IBA 02/2022 - 12/2020
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 12/2017
2	Gu-Ben-Fang-Xiao decoctionIBA 01/2021 - 01/2020
2	kaempferolIBA 12/2020 - 09/2020
2	Oxygen (Dioxygen)IBA 01/2018 - 12/2017
2	salicylhydroxamic acid (SHAM)IBA 01/2018 - 01/2016
2	Messenger RNA (mRNA)IBA 12/2017 - 01/2016
2	monomethoxypolyethylene glycol (MPEG)IBA 04/2017 - 12/2014
2	AsialoglycoproteinsIBA 04/2017 - 12/2014
1	Apolipoproteins E (ApoE)IBA 11/2024
1	Sirolimus (Rapamycin)FDA Link 04/2024
1	protein KIBA 04/2024
1	E2F1 Transcription FactorIBA 04/2024
1	Arginine (L-Arginine)FDA Link 04/2024
1	Transcription Factors (Transcription Factor)IBA 04/2024
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 03/2024
1	phytochlorinIBA 03/2024
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 02/2024
1	Actin Depolymerizing Factors (Cofilins)IBA 02/2024
1	Type I Tumor Necrosis Factor ReceptorsIBA 02/2024
1	Protein Sorting Signals (Signal Peptide)IBA 12/2023
1	Epidermal Growth Factor (EGF)IBA 12/2023

Therapy/Procedure

14	Therapeutics 09/2023 - 06/2015
5	Anesthesia 11/2023 - 09/2018
4	Electrocoagulation (Electrocautery) 12/2021 - 01/2018
3	Drug Therapy (Chemotherapy) 02/2023 - 12/2014
3	Immunotherapy 02/2023 - 01/2014
2	Lasers (Laser) 03/2024 - 04/2017
2	Photochemotherapy (Photodynamic Therapy) 03/2024 - 02/2023
2	Percutaneous Coronary Intervention 09/2023 - 12/2019
1	Renal Dialysis (Hemodialysis) 04/2024